Cargando…
A cyclic peptide retards the proliferation of DU145 prostate cancer cells in vitro and in vivo through inhibition of FGFR2
In malignancies, fibroblast growth factor receptors (FGFRs) signaling is reinforced through overexpression of fibroblast growth factors (FGFs) or their receptors. FGFR2 has been proposed as a target for cancer therapy, because both the expression and activation of FGFR2 are boosted in various malign...
Autores principales: | Zhang, Yibo, Ouyang, Man, Wang, Hailong, Zhang, Bihui, Guang, Wenhua, Liu, Ruiwu, Li, Xiaocen, Shih, Tsung‐Chieh, Li, Zhixin, Cao, Jieqiong, Meng, Qiling, Su, Zijian, Ye, Jinshao, Liu, Feng, Hong, An, Chen, Xiaojia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491194/ https://www.ncbi.nlm.nih.gov/pubmed/34766128 http://dx.doi.org/10.1002/mco2.48 |
Ejemplares similares
-
Development and Characterization of a Novel Peptide—Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors
por: Wang, Yayu, et al.
Publicado: (2021) -
FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling
por: Yang, Yiqi, et al.
Publicado: (2023) -
Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist
por: Su, Zijian, et al.
Publicado: (2023) -
Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis
por: Meng, Qilin, et al.
Publicado: (2023) -
Turning gray selenium and sublimed sulfur into a nanocomposite to accelerate tissue regeneration by isothermal recrystallization
por: Cao, Jieqiong, et al.
Publicado: (2023)